Dartmouth researchers take novel approach to fighting treatment-resistant chronic myeloid leukemia
In a paper published in the Proceedings of the National Academy of Sciences, researchers at Dartmouth's Geisel School of Medicine described a novel approach to killing chronic myeloid leukemia (CML) cells without harming normal cells, an approach that could help fight off the disease in patients who have developed resistance to standard treatment. Dartmouth is home to the Norris Cotton Cancer Center.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.